Sogo Medical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Interim and Year Ending March 31, 2018
The company provided earnings guidance for the interim and year ending March 31, 2018. For the interim, the group expected to report net sales of ¥64,899 million, operating income of ¥2,605 million, ordinary income of ¥2,608 million and profit attributable to owners of the parent of ¥1,434 million or ¥95.86 per share.
For the year, the group expected to report net sales of ¥135,566 million, operating income of ¥7,001 million, ordinary income of ¥7,016 million and profit attributable to owners of the parent of ¥4,029 million or ¥269.19 per share.